Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Globus Medical

Biotech & Life Sciences · Lower Providence Township, United States · Founded 2003 · IPO 2012 Decacorn

Globus Medical - Minimally Invasive Spine Surgery, Scoliosis

Valuation
$12B
Market cap · May/2026
Revenue
$2.94B
Latest reported FY
EBITDA
$1.05B
Latest reported FY

Investors

3 investors on Globus Medical's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 3 investors entered at this stage
Clarus Ventures
AIG Investments
Goldman Sachs

Global footprint

Where Globus Medical has talent and traffic

AI talent share
0.6% of workforce is AI talent
(19 of 3,400 staff)
Core AI110.32%
Other AI80.24%
Non-AI workforce3,38199.44%
Workforce by country
28 countries with
team presence
🇺🇸 United States81.8%
🇮🇳 India2.8%
🇦🇺 Australia2.4%
🇬🇧 United Kingdom2.3%
🇳🇱 Netherlands1.4%
Top 5 of 28 shown
Web traffic by country
76K monthly visits
across markets
🇺🇸 United States64.1%
🇮🇳 India8.4%
🇯🇵 Japan5.5%
🇬🇧 United Kingdom3.3%
🇳🇬 Nigeria2.6%
Top 5 markets shown

Patent intelligence

$930M patent portfolio · 1,196 active families

Estimated portfolio value
$930M
7.9% of market cap · 17.8× the top peer PROCEPT BioRobotics ($52M)
1,196 active patent families
Where Globus Medical innovates Biomedical engineeringPhysical medicine and rehabilitationSpinal columnMechanical engineeringReoperative surgery

Where Globus Medical concentrates vs peers

Each axis is a top-10 topic across Globus Medical and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Globus Medical's 6 investments and acquisitions.

Every disclosed deal where Globus Medical appeared as a backer or acquirer, 2011–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across Globus Medical's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Globus Medical's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        What the market is saying about Globus Medical

        An AI-synthesized read of the highest-engagement posts about Globus Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Globus Medical on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.